Toward an optimal “antiplatelet” dose of aspirin: Preliminary observations

This publication has 14 references indexed in Scilit:

• Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
  Stroke, 1988
• Secondary prevention of vascular disease by prolonged antiplatelet treatment
  BMJ, 1988
• Platelet aggregation in human whole blood after chronic administration of aspirin
  Thrombosis Research, 1987
• Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man
  Prostaglandins, 1986
• Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.
  Stroke, 1985
• Prostacyclin infusion in acute cerebral infarction
  Neurology, 1984
• Platelet Model for Halothane‐Induced Effects on Nucleotide Metabolism Applied to Malignant Hyperthermia
  Acta Anaesthesiologica Scandinavica, 1984
• Dosage frequency for suppression of platelet function by low dose aspirin therapy
  Thrombosis Research, 1982
• “COMPLICATED MIGRAINE” ITS ASSOCIATION WITH INCREASED PLATELET AGGREGABILITY AND ABNORMAL PLASMA COAGULATION FACTORS
  Headache: The Journal of Head and Face Pain, 1975
• Defective Platelet Disaggregation Associated with Occlusive Arterial Diseases
  Angiology, 1973